Posts | Mounjaro News - Actualite tirzepatide

GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More

France fines Novo Nordisk and Eli Lilly over ads for anti-obesity drugs - Le Monde.fr

‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?

Obesity meds push pharma returns higher, overtaking oncology: report - FirstWord Pharma

Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials | Eli Lilly and Company

Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes

Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket

FDA Moves to Permanently Close the Door on Compounded GLP-1s - Pharmacy Times

Price pressure on weight-loss drugs slows Eli Lilly’s growth engine in the first quarter

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies